Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus — Stella

Home/Type 2 Diabetes/

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Peking University People's Hospital, Beijing, Beijing Municipality

Key details

Phase

Large-scale testing

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Enrollment target

~360 participants

Started

August 2025

Primary completion

October 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.